- Home
- PAVS vs CRVO Comparison
PAVS vs CRVO Comparison
Compare PAVS & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- CRVO
- Stock Information
- Founded
- PAVS 2004
- CRVO 2001
- Country
- PAVS United States
- CRVO United States
- Employees
- PAVS N/A
- CRVO N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- CRVO Health Care
- Exchange
- PAVS Nasdaq
- CRVO Nasdaq
- Market Cap
- PAVS 89.6M
- CRVO 95.4M
- IPO Year
- PAVS 2019
- CRVO N/A
- Fundamental
- Price
- PAVS $1.03
- CRVO $8.49
- Analyst Decision
- PAVS
- CRVO Strong Buy
- Analyst Count
- PAVS 0
- CRVO 8
- Target Price
- PAVS N/A
- CRVO $25.43
- AVG Volume (30 Days)
- PAVS 26.8K
- CRVO 453.1K
- Earning Date
- PAVS 01-01-0001
- CRVO 05-20-2025
- Dividend Yield
- PAVS N/A
- CRVO N/A
- EPS Growth
- PAVS N/A
- CRVO N/A
- EPS
- PAVS N/A
- CRVO N/A
- Revenue
- PAVS $6,613,273.00
- CRVO $9,737,974.00
- Revenue This Year
- PAVS N/A
- CRVO N/A
- Revenue Next Year
- PAVS N/A
- CRVO N/A
- P/E Ratio
- PAVS N/A
- CRVO N/A
- Revenue Growth
- PAVS 2.50
- CRVO 36.29
- 52 Week Low
- PAVS $0.32
- CRVO $1.80
- 52 Week High
- PAVS $1.50
- CRVO $25.69
- Technical
- Relative Strength Index (RSI)
- PAVS 17.87
- CRVO 46.29
- Support Level
- PAVS $1.22
- CRVO $8.40
- Resistance Level
- PAVS $1.40
- CRVO $11.79
- Average True Range (ATR)
- PAVS 0.06
- CRVO 0.99
- MACD
- PAVS -0.03
- CRVO -0.19
- Stochastic Oscillator
- PAVS 6.40
- CRVO 10.45
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.